KERRY KANE: Open Payments
NPI 1831150796 · ELWOOD, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$171 in 9 payments from 8 companies in 2025. Trend: 2023 $91 · 2024 $262 · 2025 $171
Food & beverage: $171
| Company | Payments | Amount |
|---|---|---|
| Exact Sciences Corporation | 2 | $30 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $26 |
| AstraZeneca Pharmaceuticals LP | 1 | $24 |
| Lilly USA, LLC | 1 | $22 |
| Vanda Pharmaceuticals Inc. | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Amgen Inc. | 1 | $16 |
| Inspire Medical Systems, Inc. | 1 | $14 |
Products named: Kerendia, MOUNJARO, FANAPT, REXULTI, OTEZLA, Cologuard Collection Kit, The Cologuard Plus Collection Kit, INSPIRE.
Industry payments across IN — which companies pay providers there.
